Surfactant replacement therapy in acute respiratory distress syndrome from viral pneumonia.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 8814477.
- Also identified by PMC identifier 7095348.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A modified natural surfactant was administered to a patient with life-threatening adult respiratory distress syndrome caused by viral pneumonia. Subsequently, there was a marked improvement in gas exchange. In order to assess the mechanism for improved oxygenation, computed tomography of the lungs was done. Quantitative analysis of the scans taken before and after surfactant administration indicates that improvement in gas exchange was largely due to the expansion of underinflated and collapsed lung areas. Although this is a single case report, it provides insight into the possible beneficial effect of instilled surfactant in severe respiratory distress from viral pneumonia.
Medical subject headings
- Biological Products
- Phospholipids
- Pulmonary Surfactants
- Respiratory Distress Syndrome